Cost of human immunodeficiency virus infection in Italy, 2007–2009: effective and expensive, are the new drugs worthwhile?

BACKGROUND: In recent years, the increased efficacy and effectiveness of antiretroviral treatment has led to longer survival of patients infected with human immunodeficiency virus (HIV), but has also raised the question of what happens to consumption of resources. Early highly active antiretroviral...

Descripción completa

Detalles Bibliográficos
Autores principales: Rizzardini, Giuliano, Restelli, Umberto, Bonfanti, Paolo, Porazzi, Emanuele, Ricci, Elena, Foglia, Emanuela, Carenzi, Laura, Croce, Davide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3439221/
https://www.ncbi.nlm.nih.gov/pubmed/22973114
http://dx.doi.org/10.2147/CEOR.S35194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3439221/
https://www.ncbi.nlm.nih.gov/pubmed/22973114
http://dx.doi.org/10.2147/CEOR.S35194

Ejemplares similares